Canola Oil Multi-center Intervention Trial II
NCT03054779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2023-08-21
Summary
Building on the findings from the investigators previous study, COMIT I, the purpose of the COMIT II study is to supplement the DEXA measurement of body composition with a supplementary DEXA measurement of visceral adipose tissue and to specifically target the impact of oleic acid consumption on body composition as the primary objective. COMIT II also will include analysis of fatty acid ethanolamines (FAEs) and their precursors to elucidate the mechanisms by which canola oil may be modifying body composition, measurement of endothelial function, inflammatory, adiposity and insulin sensitivity biomarkers, and genetic analyses.
Conditions
- Cardiovascular Disease
- Metabolic Syndrome
Interventions
- OTHER
-
Canola Oil
Regular canola oil will be iso-calorically incorporated into fruit smoothies made with milk and consumed twice daily.
- OTHER
-
High oleic acid canola oil
High oleic acid canola oil will be iso-calorically incorporated into fruit smoothies made with milk and consumed twice daily.
- OTHER
-
Western diet oil combination
A typical "Western diet" fat intake as a control treatment, comprised of 11% MUFA, 11% PUFA (9% omega-6 fatty acids and 2% omega-3 fatty acids), and 13% SFA, will be iso-calorically incorporated into fruit smoothies made with milk and consumed twice daily
Sponsors & Collaborators
-
Canola Council of Canada
collaborator OTHER -
University of Manitoba
collaborator OTHER -
Laval University
collaborator OTHER -
Unity Health Toronto
collaborator OTHER -
St. Boniface Hospital
collaborator OTHER -
Penn State University
lead OTHER
Principal Investigators
-
Penny M Kris-Etherton, PhD · Penn State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- United States
Study Locations
More Related Trials
-
Impact of n-3 Polyunsaturated Fatty Acids in a Protein-enriched Diet With Low GI in Type 2 Diabetes Patients
NCT01474603 ·Status: COMPLETED
-
Saturated Fat Versus Monounsaturated Fat and Insulin Action
NCT01612234 ·Status: COMPLETED ·Phase: NA
-
Effect of Conjugated Linoleic Acid Supplement on Body Composition
NCT00347373 ·Status: COMPLETED ·Phase: NA
-
Effect of Dose of Buglossoides Oil on EPA Accrual and on the Inflammatory Response
NCT02540759 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Study Products Containing Varying Quantities of Docosahexaenoic Acid (DHA)
NCT01174134 ·Status: COMPLETED ·Phase: NA
-
The Effect of n-3 PUFA Plant Oil Intake on Human Metabolism
NCT03484988 ·Status: UNKNOWN ·Phase: NA
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
NCT00504309 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
The Acute Effects of Oleic Acid Enriched-diets on Lipids, Insulin Sensitivity and Serum Inflammatory Markers
NCT01124487 ·Status: COMPLETED ·Phase: NA
-
Vit D3 and Omega 3 in Chemo Induced Neuropathy
NCT02294149 ·Status: UNKNOWN ·Phase: PHASE3
-
Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes
NCT04327713 ·Status: UNKNOWN
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of Fish Oils on Inflammation and Insulin Resistance
NCT00579436 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Supplementation and Resistance Training
NCT02617511 ·Status: COMPLETED ·Phase: NA
-
FILIP: Fat Intake, Inflammation and LIPids
NCT06640036 ·Status: COMPLETED ·Phase: NA
-
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
NCT02096757 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of a Fish Oil Containing Lipid Emulsion
NCT01176695 ·Status: COMPLETED ·Phase: PHASE3
-
Dietary Fat, Eicosanoids and Breast Cancer Risk
NCT01824498 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Effects of Omega 3 Fatty Acids in the Context of Cancer Prevention
NCT05427604 ·Status: COMPLETED ·Phase: NA
-
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
NCT04485871 ·Status: RECRUITING ·Phase: NA
-
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
NCT01422317 ·Status: COMPLETED ·Phase: PHASE3
-
A Human In Vivo Feeding Study Of The Blood Monocyte Response To Dietary Lipid Intake
NCT02101346 ·Status: TERMINATED ·Phase: NA
-
Vitamin D and Omega-3 Inhibit Metabolic Syndrome
NCT01326442 ·Status: COMPLETED ·Phase: PHASE3
-
Intestinal Tolerance & Health Effects of Daily Consumption of Two Eggs With Fatty Acid Profile Related to Metabolic Disorders
NCT04583657 ·Status: COMPLETED ·Phase: NA